Orthofix Medical Inc. announced the appointment of Max Reinhardt as President of the Global Spine business effective June 10, 2024. Reinhardt will serve on the Executive Leadership Team and be responsible for leading SeaSpine, the Company?s global spine and biologics business. Reinhardt?s experience spans more than 30 years in MedTech and pharmaceuticals, assuming positions of increasing responsibility at Johnson & Johnson, including serving as Worldwide President, DePuy Synthes Spine, achieving the number two market share position in the competitive spine market.

Additionally, Reinhardt served as Vice President, Marketing U.S. Orthopedics, and Global Franchise Leader and Worldwide President of Joint Reconstruction, Sports Medicine and Power Tools. Reinhardt has worked closely with key opinion leaders and launched market-leading biologics and implant solutions in spine surgery, joint replacement, orthopedic trauma and early intervention, supported by a robust technique-based professional education agenda. Prior to his experience with Johnson & Johnson, Reinhardt had senior leadership positions with Steris and Olympus in Europe.

Most recently, Reinhardt served in different leadership roles for Pacira Biosciences, a company focused on providing innovative non-opioid pain management solutions. Reinhardt earned his undergraduate diploma from Sparsholt College, Hampshire, U.K. and a Master of Science degree from the University of Hull, U.K.